Utah Retirement Systems Arvinas, Inc. Transaction History

Utah Retirement Systems

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$60.27 - $81.57 $221,673 - $300,014	-3,678 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$65.85 - $96.21 $936,979 - $1.37 Million	-14,229 Reduced 79.46%	3,678 $302,000
Q3 2021 Nov 16, 2021	BUY	$73.2 - $107.87 $1.31 Million - $1.93 Million	17,907 New	17,907 $1.47 Million
Q4 2020 Feb 16, 2021	SELL	$20.19 - $84.93 $331,459 - $1.39 Million	-16,417 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$22.99 - $36.34 $377,426 - $596,593	16,417 New	16,417 $388,000

229

68.4M

226K

285K

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.02B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

Stay updated on Utah Retirement Systems with notifications on news.